Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference
November 10 2021 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a
company advancing medicines to better treat addictions and drug
overdose, today announced that members of the company’s senior
management team will participate in the 12th Jefferies London
Healthcare Conference virtually on Thursday, November 18 and
Friday, November 19. Management will participate in investor 1x1
meetings on both days. A webcast of the event will be available
from November 18, 2021, 8:00 AM GMT / 3:00 AM ET on the
Opiant website.
About Opiant Pharmaceuticals,
Inc. Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information
visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins, Opiant(310)
598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Sep 2023 to Sep 2024